Quintessence Biosciences' Unattributed Round

Quintessence Biosciences raised a round of funding on February 15, 2008.

Quintessence Biosciences is a biopharmaceutical company focused on development of-based therapeutics as anti-cancer agents. The Company's products are based on the EVade Ribonuclease Technology which …

Articles about Quintessence Biosciences' Unattributed Round: